| Bioactivity | BChE-IN-23 (compound 2a) is a BChE inhibitor with an IC50 value of 21 nM. BChE-IN-23 can be used in Alzheimer's disease (AD) research[1]. |
| Name | BChE-IN-23 |
| CAS | 2020357-32-6 |
| Formula | C20H19FN2O |
| Molar Mass | 322.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lee S H, et al. Radiosynthesis and whole‐body distribution in mice of a 18F‐labeled azepino [4, 3‐b] indole‐1‐one derivative with multimodal activity for the treatment of Alzheimer's disease. Archiv der Pharmazie, 2023: e2300491. |
BChE-IN-23
CAS: 2020357-32-6 F: C20H19FN2O W: 322.38
BChE-IN-23 (compound 2a) is a BChE inhibitor with an IC50 value of 21 nM. BChE-IN-23 can be used in Alzheimer's disease
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.